Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONEste recurso está restringido
http://dx.doi.org/10.1089/ars.2014.5952 |
Metadatos
Título
Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic ImplicationsFecha de publicación
2015-03-10Editor
Mary Ann LiebertCita bibliográfica
APOSTOLOVA, Nadezda; VÍCTOR, Víctor M. Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications. Antioxidants & Redox Signaling (2015), v. 22, n. 8, pp. 686-729Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
http://online.liebertpub.com/toc/ars/22/8Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Mitochondrial function and specifically its implication in cellular redox/oxidative balance is fundamental in controlling the life and death of cells, and has been implicated in a wide range of human pathologies. In ... [+]
Mitochondrial function and specifically its implication in cellular redox/oxidative balance is fundamental in controlling the life and death of cells, and has been implicated in a wide range of human pathologies. In this context, mitochondrial therapeutics, particularly those involving mitochondria-targeted antioxidants, have attracted increasing interest as potentially effective therapies for several human diseases. For the past 10 years, great progress has been made in the development and functional testing of molecules that specifically target mitochondria, and there has been special focus on compounds with antioxidant properties. In this review, we will discuss several such strategies, including molecules conjugated with lipophilic cations (e.g.,triphenylphosphonium) or rhodamine, conjugates of plant alkaloids, amino-acid- and peptide-based compounds, and liposomes. This area has several major challenges that need to be confronted. Apart from
antioxidants and other redox active molecules, current research aims at developing compounds that arecapable of modulating other mitochondria-controlled processes, such as apoptosis and autophagy. Multiple chemically different molecular strategies have been developed as delivery tools that offer broad opportunities for mitochondrial manipulation. Additional studies, and particularly in vivo approaches under physiologically
relevant conditions, are necessary to confirm the clinical usefulness of these molecules. [-]
Publicado en
Antioxidants & Redox Signaling (2015), v. 22, n. 8Derechos de acceso
http://rightsstatements.org/vocab/CNE/1.0/
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/restrictedAccess
Aparece en las colecciones
- MED_Articles [667]